Using this construct we screened a kinase inhibitor library and discovered that GSK-3β repressed let-7 production in ovarian cancer cells, thus uncovering GSK-3β as a novel target for therapeutic intervention. This evidence concerns the gene GSK3B and ovarian carcinoma.